Quantum-Si (QSI) CFO Jeffry Keyes Sells $3.7K of Stock
Chief Financial Officer Jeffry Keyes sold 4,117 shares of Quantum-Si stock in late June.
Reviewed by automated data checks against the source filing. How we make and check alerts
Jeffry Keyes, Chief Financial Officer at Quantum-Si incorporated ($QSI), sold 4,117 shares at an average price of $0.90, worth about $3,705.30, on June 23, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $QSI is up 1.1% after 1 week, down 10.2% after 1 month and up 27.3% to date (from the $0.88 close on Jun 23, 2026).
QSI
Quantum-Si incorporated
Key Points
- Quantum-Si Chief Financial Officer Jeffry Keyes sold 4,117 shares of QSI stock on June 23, 2026, for a total value of $3,705.30 at $0.90 per share.
- The transaction follows earlier June insider sales by CEO Jeffrey Alan Hawkins, General Counsel Christian Lapointe, and Chief Product Officer John Vieceli.
- Quantum-Si shares trade near $0.83, well below their 52-week high of $3.10 and above their 52-week low of $0.69.
Get $QSI trade alerts by text
We text you when insiders, Congress or big funds trade $QSI. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Quantum-Si incorporated alert may contain errors. Disclosures
Quantum-Si CFO Jeffry Keyes Sells Shares
Quantum-Si (NasdaqGM: QSI) Chief Financial Officer Jeffry Keyes sold 4,117 shares of company stock on June 23, 2026. The transaction took place at a price of $0.90 per share, totaling roughly $3,705.30. Insider sales do not automatically signal a negative outlook, and executives routinely part with shares for personal financial planning or tax obligations.
Recent Insider Transactions at Quantum-Si
Keyes's sale on June 23 follows an active stretch of executive transactions at Quantum-Si. On the same day, President and CEO Jeffrey Alan Hawkins sold 11,311 shares worth $10,179.90 at $0.90 each, while General Counsel Christian Lapointe offloaded 7,794 shares valued at $7,014.60. Chief Product Officer John Vieceli also sold 15,112 shares on June 23 for $13,600.80 at $0.90 per share. These followed previous sales by the same group on June 22, continuing a flurry of executive filings.
QSI Stock Performance and Valuation
Quantum-Si shares traded near $0.83 around the time of the filings. The stock has experienced a wide trading range over the past year, hitting a 52-week low of $0.69 and a 52-week high of $3.10. Its 50-day moving average sits at $0.78, while its 200-day moving average rests higher at $0.97. The medical device company carries a market capitalization of roughly $165.48 million.
Analysts Set New Price Targets
Wall Street analysts maintain a cautious outlook on Quantum-Si shares. HC Wainwright & Co. reiterated its Buy rating on the stock with a price target of $4.00 on September 29, 2026. Across the broader analyst community, the stock holds a consensus view with a mean price target of $2.30 based on three analyst opinions, with targets ranging from a low of $1.00 to a high of $4.00.
Inside Quantum-Si's Business
Quantum-Si is a life sciences firm headquartered in Branford, Connecticut. The company builds proprietary single-molecule detection platforms applied to proteomics, aiming to advance next-generation protein sequencing. Its product lineup includes Platinum instruments, library preparation kits, sequencing kits, and cloud-based data analysis software designed to streamline amino acid level resolution.
What to Watch Next for QSI
Investors will look toward Quantum-Si's upcoming earnings report, scheduled for November 5, 2026, for updates on revenue growth and product adoption. Insiders will continue filing Form 4 reports whenever they buy or sell shares, offering a regular window into executive sentiment.
Related Filing Alerts
Source: Jeffry Keyes's Form 4 filing on $QSI (Jun 23, 2026). Find the original filing: QSI Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts